BRONCHIECTASIS
Clinical trials for BRONCHIECTASIS explained in plain language.
Never miss a new study
Get alerted when new BRONCHIECTASIS trials appear
Sign up with your email to follow new studies for BRONCHIECTASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to tame chronic lung disease Flare-Ups
Disease control Not yet recruitingThis study is testing a new drug, GSK3862995B, to see if it can help adults with bronchiectasis, a long-term lung condition. The main goal is to see if the drug can reduce the number of times a person's symptoms suddenly get much worse, known as exacerbations. About 400 participa…
Matched conditions: BRONCHIECTASIS
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Feb 27, 2026 15:19 UTC
-
New device aims to help patients breathe easier by clearing stubborn lung mucus
Symptom relief Not yet recruitingThis study is testing whether a new device called Simeox 200 can help adults with bronchiectasis clear thick mucus from their lungs more effectively. Participants will use the device at home for two weeks to see if it improves their breathing, reduces coughing, and makes them fee…
Matched conditions: BRONCHIECTASIS
Phase: NA • Sponsor: Inogen Inc. • Aim: Symptom relief
Last updated Apr 01, 2026 14:42 UTC
-
Scientists probe Mind-Body link in chronic lung disease
Knowledge-focused Not yet recruitingThis study aims to understand how anxiety and depression might be linked to more frequent flare-ups in people with bronchiectasis, a chronic lung disease. Researchers will enroll 300 adults with the condition to track their mental health and disease progression over five years. T…
Matched conditions: BRONCHIECTASIS
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC